Adrenal Suppression and Adrenal Recovery Induced by Megestrol Acetate
NCT00575029 is an interventional trial sponsored by University of Arkansas. As of 21 Nov 2026, it is completed. It studies Megestrol in Adrenal Insufficiency. The registry lists an enrollment of 7 participants at 1 site in 1 country. The registry lists a start date of 30 Apr 2004 and a primary completion date of 31 Dec 2004.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00575029 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | University of Arkansas |
| Enrollment | 7 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Adrenal Insufficiency |
| Drugs | Megestrol |
| Start | 30 Apr 2004 |
| Primary completion | 31 Dec 2004 |
| Study completion | 31 Dec 2004 |
| Last update posted | 29 Aug 2011 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- donald l bodenner
associate professor
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arkansas for Medical Sciences
Little Rock
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT00575029
Each answer restates registry values shown on this page.
What is NCT00575029?
NCT00575029 is an interventional trial sponsored by University of Arkansas. It studies Megestrol in Adrenal Insufficiency.
Who leads NCT00575029?
The registry names donald l bodenner (principal investigator, associate professor) as the overall official.
Where does NCT00575029 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT00575029 study?
The registered drug and biological interventions are Megestrol.
When did NCT00575029 end?
The registry lists a primary completion date of 31 Dec 2004 and a study completion date of 31 Dec 2004. The sponsor last updated the record on 29 Aug 2011.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.